# Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study

> **NCT02792478** · — · COMPLETED · sponsor: **Amgen** · enrollment: 238 (actual)

## Conditions studied

- RAS Wild Type mCRC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02792478
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-06
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792478, "Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02792478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*